Found 6 matching trials
Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon PHASE1 LA rVSVΔG-ZEBOV-GP -02-PED is a Phase 1/2, randomized, controlled open labe...
Show More Location
Centre de Recherches Médicales de Lambaréné
Learn More & Join Trial
African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola PHASE2 This is a randomized, placebo-controlled, multi-site, double-blind trial of...
Show More Learn More & Join Trial
Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001) PHASE1 This is a study of the anti-Ebola vaccine vesicular stomatitis virus (VSV) ...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012) PHASE3 The study evaluated the safety and immunogenicity of 3 consistency lots and...
Show More Location
Multiple Locations
Learn More & Join Trial
Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004) PHASE1 Ebola virus has infected and killed people, mostly in Africa. In 2014, the ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002) PHASE1 Ebola virus has infected and killed people, mostly in Africa. In 2014, the ...
Show More Location
Multiple Locations
Learn More & Join Trial